Oncomark Ltd - Product Pipeline Analysis, 2018 Update


Oncomark Ltd (Oncomark) is a diagnostics company that develops prognostic and predictive assays for the treatment of cancer. The company’s product include OncoMasTR, is a novel prognostic assay used to identify the early stage breast cancer. It has a range of tissue-based biomarker assays under development which are suited to Pharmacodynamic and Patient Stratification studies. Oncomark‘s research projects are primarily taken for breast cancer, prostate cancer, colorectal cancer and melanoma skin cancer. The company work with other organizations through research and development, technology and commercial collaborations to develop novel products. Oncomark is headquartered in Dublin, Ireland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Oncomark Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Oncomark Ltd Company Overview
Oncomark Ltd Company Snapshot
Oncomark Ltd Pipeline Products and Ongoing Clinical Trials Overview
Oncomark Ltd – Pipeline Analysis Overview
Oncomark Ltd - Key Facts
Oncomark Ltd - Major Products and Services
Oncomark Ltd Pipeline Products by Development Stage
Oncomark Ltd Pipeline Products Overview
OncoMasTR - Bladder Cancer
OncoMasTR - Bladder Cancer Product Overview
OncoMasTR - Breast Cancer
OncoMasTR - Breast Cancer Product Overview
OncoMasTR - Colorectal Cancer
OncoMasTR - Colorectal Cancer Product Overview
OncoMasTR - Melanoma
OncoMasTR - Melanoma Product Overview
OncoMasTR - Multiple Myeloma
OncoMasTR - Multiple Myeloma Product Overview
OncoMasTR - Predictive Biomarker Test
OncoMasTR - Predictive Biomarker Test Product Overview
OncoMasTR - Prostate Cancer
OncoMasTR - Prostate Cancer Product Overview
Oncomark Ltd - Key Competitors
Oncomark Ltd - Key Employees
Oncomark Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Oncomark Ltd, Recent Developments
Feb 15, 2017: OncoMark Secures €2.1 Million Investment to Commercialise New Diagnostic Test for Breast Cancer
Nov 24, 2010: OncoMark Appoints Dara FitzGerald As CEO
About GlobalData
Contact Us
List of Tables
Oncomark Ltd Pipeline Products and Ongoing Clinical Trials Overview
Oncomark Ltd Pipeline Products by Equipment Type
Oncomark Ltd Pipeline Products by Indication
Oncomark Ltd, Key Facts
Oncomark Ltd, Major Products and Services
Oncomark Ltd Number of Pipeline Products by Development Stage
Oncomark Ltd Pipeline Products Summary by Development Stage
OncoMasTR - Bladder Cancer - Product Status
OncoMasTR - Bladder Cancer - Product Description
OncoMasTR - Breast Cancer - Product Status
OncoMasTR - Breast Cancer - Product Description
OncoMasTR - Colorectal Cancer - Product Status
OncoMasTR - Colorectal Cancer - Product Description
OncoMasTR - Melanoma - Product Status
OncoMasTR - Melanoma - Product Description
OncoMasTR - Multiple Myeloma - Product Status
OncoMasTR - Multiple Myeloma - Product Description
OncoMasTR - Predictive Biomarker Test - Product Status
OncoMasTR - Predictive Biomarker Test - Product Description
OncoMasTR - Prostate Cancer - Product Status
OncoMasTR - Prostate Cancer - Product Description
Oncomark Ltd, Key Employees
List of Figures
Oncomark Ltd Pipeline Products by Equipment Type
Oncomark Ltd Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook